esketamine kalceks 5 mg/ml inj./inf. sol. i.v./i.m. amp.
as kalceks a.s. - esketamine hydrochloride 5,77 mg/ml - eq. esketamine 5 mg/ml - solution for injection/infusion - 5 mg/ml - esketamine hydrochloride 5.77 mg/ml - esketamine
esketamine kalceks 25 mg/ml inj./inf. sol. i.v./i.m. amp.
as kalceks a.s. - esketamine hydrochloride 28,85 mg/ml - eq. esketamine 25 mg/ml - solution for injection/infusion - 25 mg/ml - esketamine hydrochloride 28.85 mg/ml - esketamine
esketamine kalceks 25 mg/ml inj./inf. sol. i.v./i.m. amp.
as kalceks a.s. - esketamine hydrochloride 28,85 mg/ml - eq. esketamine 25 mg/ml - solution for injection/infusion - 25 mg/ml - esketamine hydrochloride 28.85 mg/ml - esketamine
ketamine injection
umedica laboratories pvt ltd plot 221 g.i.d.cvapi-396195 - ketamine hcl - injection - ketamine hcl 500mg/10ml - other general anesthetics
ketamine hydrochloride- ketamine hydrochloride injection
fresenius kabi usa, llc - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine hydrochloride injection is indicated: - as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. - for the induction of anesthesia prior to the administration of other general anesthetic agents. - as a supplement to other anesthetic agents. - ketamine hydrochloride injection is contraindicated in patients for whom a significant elevation of blood pressure would constitute a serious hazard [see warnings and precautions (5.1)] . - ketamine hydrochloride injection is contraindicated in patients with known hypersensitivity to ketamine or to any excipient [see adverse reactions (6)] . risk summary there are no adequate and well-controlled studies of ketamine hydrochloride injection in pregnant women. in animal reproduction studies in rats developmental delays (hypoplasia of skeletal tissues) were noted at 0.3 times the human intramuscular dose of 10 mg/kg. in rabbits, developmental delays and increased fetal resorptions were noted at 0.6 times the
ketamine mylan
viatris limited - ketamine hydrochloride 115.3 mg/ml equivalent to ketamine 100 mg/ml - solution for injection - 200 mg/2ml - active: ketamine hydrochloride 115.3 mg/ml equivalent to ketamine 100 mg/ml excipient: benzethonium chloride nitrogen water for injection - ketamine is indicated: · as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses' for longer procedures · for the induction of anaesthesia prior to the administration of other general anaesthetic agents · to supplement low-potency agents' such as nitrous oxide.
ketamine - fresenius 50mg/1ml
fresenius kabi manufacturing (sa) (pty) ltd - ketamine hydrochloride - injection - each 1ml injection contains: ketamine hydrochloride equiv. to 50mg ketamine
spravato solution
janssen inc - esketamine (esketamine hydrochloride) - solution - 28mg - esketamine (esketamine hydrochloride) 28mg - miscellaneous antidepressants
ketalar ketamine 200mg/2ml (as hydrochloride) injection vial
pfizer australia pty ltd - ketamine hydrochloride, quantity: 115.3 mg/ml (equivalent: ketamine, qty 100 mg/ml) - injection, solution - excipient ingredients: water for injections; benzethonium chloride - ketalar is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketalar is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents, and 3. to supplement low-potency agents, such as nitrous oxide.
phoenix ketamine injection
phoenix pharm distributors ltd - ketamine hydrochloride - ketamine hydrochloride 100 g/litre - anaesthetic